ArticleCancer science2021

Deubiquitinating enzyme inhibitor alleviates cyclin A1-mediated proteasome inhibitor tolerance in mixed-lineage leukemia.

Maolin Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.